Anti-metastatic potential of anthocyanins and their metabolites (metabotypes) on cancer cell lines with different phenotypes - role of intestinal fermentation and metabolization.

花青素及其代谢物(代谢型)对不同表型癌细胞系的抗转移潜力 - 肠道发酵和代谢的作用。

基本信息

项目摘要

With about 20-30%, cancer is the second leading cause of death in Germany. The aggressiveness of a tumor depends on its metastasizing potential, which is characterized by the steps of invasion, intravasation and extravasation. New pharmacological therapeutics particularly aim at inhibiting cell adhesion molecules of tumor cells, e.g. integrins, selectins, and members of the immunoglobulin superfamily whose expression and pattern is strongly associated with the metastatic potential. They aim at the inhibition of tumor cell extravasation into the tissues and the formation of metastases. Nutritive factors that are able to influence these processes are currently being intensively investigated. Primarily, anthocyanins (ACN) belonging to the secondary plant ingredients are of particular importance. Their bioavailability is low, and they reach the lower gastrointestinal tract largely unchanged. Here, microbial fermentation products may be generated which could induce anti-carcinogenic effects after being absorbed into the systemic circulation. Preliminary experiments showed that ACN fermented by bacteria typically present in the human intestinal microbiota such as E. coli and Haf. alvei significantly reduced the migration of colorectal carcinoma and pancreatic carcinoma cells in vitro. Similarly, after the intake of an ACN-rich juice, ACN and their metabolites isolated from human plasma (PiACN) were able to influence tumor cell migration, but not to affect growth-associated parameters. This anti-migrative effect was not only dependent on the time of blood collection (60 min or 14 days after juice intake), but also on the individual subject. It is completely unclear which compounds are responsible for these effects and by which mechanism they induce these effects. The aim of the proposal is to investigate which ACNs and metabolites were generated after a 4-week-intervention study with an ACN-rich juice and if they are able to induce an anti-cancerogenic effect. The PiACN derived from all subjects before and after the intervention phase will be prepared by solid phase extraction and used for the in vitro functional studies. Pancreatic (Panc-1, Asp-1) and colon (HT-29, Caco-2) cancer cell lines as well as endothelial cells (HUVEC) will be investigated regarding their expression levels of β integrins, selectins and members of the immunoglobulin superfamily. The involvement of relevant signaling pathways (FAK-SFK- and redox-sensitive NF-B-associated signaling pathway) are also of interest. Besides the effects of PiACN on these cells itself, its effect regarding with pharmacologically relevant compounds is to be investigated in vitro in order to identify possible interactions. The analysis of blood and fecal samples with regard to ACN and their metabolites, as well as the composition of the intestinal microbiota, should provide further information on the interactions between function and metabolism.
癌症是德国第二大死因,约占20-30%。肿瘤的侵袭性取决于其转移潜力,其特点是浸润、内渗和外渗。新的药物治疗方法特别针对抑制肿瘤细胞的细胞粘附分子,如整合素、选择素和免疫球蛋白超家族成员,其表达和模式与转移潜力密切相关。它们的目的是抑制肿瘤细胞向组织外渗和转移的形成。目前正在深入研究能够影响这些过程的营养因素。首先,花青素(ACN)属于次生植物成分,具有特别重要的意义。它们的生物利用度很低,到达下胃肠道时基本不变。在此过程中,微生物发酵产物被吸收进入体循环后可能产生抗癌作用。初步实验表明,ACN由大肠杆菌和Haf等人类肠道微生物群中常见的细菌发酵而成。肺泡在体外可明显减少结直肠癌和胰腺癌细胞的迁移。同样,在摄入富含ACN的果汁后,从人血浆中分离出的ACN及其代谢物(PiACN)能够影响肿瘤细胞的迁移,但不影响生长相关参数。这种抗迁移作用不仅取决于采血时间(果汁摄入后60分钟或14天),而且取决于个体受试者。目前还完全不清楚是哪些化合物造成了这些影响,以及它们通过何种机制引起了这些影响。该提案的目的是研究在使用富含acn的果汁进行为期四周的干预研究后产生了哪些acn和代谢物,以及它们是否能够诱导抗癌作用。所有受试者干预前后的PiACN将采用固相萃取法制备,用于体外功能研究。胰腺癌(Panc-1, Asp-1)和结肠癌(HT-29, Caco-2)细胞系以及内皮细胞(HUVEC)将被研究其β整合素,选择素和免疫球蛋白超家族成员的表达水平。相关信号通路(FAK-SFK-和氧化还原敏感NF-b相关信号通路)的参与也令人感兴趣。除了PiACN对这些细胞本身的作用外,其与药理学相关化合物的作用还有待于在体外研究,以确定可能的相互作用。对血液和粪便样本进行ACN及其代谢物的分析,以及肠道微生物群的组成,应能提供有关功能和代谢之间相互作用的进一步信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Privatdozentin Dr. Sabine Kuntz其他文献

Privatdozentin Dr. Sabine Kuntz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

Metastatic Units 介导卵巢癌腹腔转移的分子机制及靶向阻遏
  • 批准号:
    81772787
  • 批准年份:
    2017
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
放射性大环酮或大环内酰胺衍生物靶向放射-化学治疗恶性肿瘤的基础研究
  • 批准号:
    30770603
  • 批准年份:
    2007
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

ESR1 mutation profiling identifies potential drivers of metastatic breast cancer
ESR1 突变分析确定了转移性乳腺癌的潜在驱动因素
  • 批准号:
    MR/X018199/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
University of Wisconsin Prostate SPORE
威斯康星大学前列腺孢子
  • 批准号:
    10555398
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Role and Theranostics Potential of Enolase in Prostate Cancer Health Disparities
烯醇化酶在前列腺癌健康差异中的作用和治疗潜力
  • 批准号:
    10649164
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Revisiting Antiangiogenic Therapy to Target Hormone-Sensitive Prostate Cancer Metabolism
重新审视抗血管生成疗法以靶向激素敏感的前列腺癌代谢
  • 批准号:
    10671250
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
血管生成素2/Tie2信号对胰腺神经内分泌肿瘤肝转移的调控
  • 批准号:
    10746299
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Understanding the role of non-coding RNAs in intercellular communication and how its potential for the detection and inhibition of pre-metastatic canc
了解非编码 RNA 在细胞间通讯中的作用及其检测和抑制转移前癌症的潜力
  • 批准号:
    2885885
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
Project 1: Tumor Microenvironment Initiators of the Metastatic Cascade in High-Risk Prostate Cancer
项目1:高危前列腺癌转移级联的肿瘤微环境启动因素
  • 批准号:
    10555400
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer
小细胞外囊泡作为头颈癌预后和治疗反应的生物标志物
  • 批准号:
    10659374
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Targeting myeloid suppression to enhance anti-tumor immunity in breast cancer
靶向骨髓抑制以增强乳腺癌的抗肿瘤免疫力
  • 批准号:
    10720795
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Understanding how the interaction between Lag3 deficiency and hypercholesterolemia impact anti-tumor immunity and cardiovascular disease in a melanoma model
了解 Lag3 缺乏与高胆固醇血症之间的相互作用如何影响黑色素瘤模型中的抗肿瘤免疫和心血管疾病
  • 批准号:
    10637369
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了